[HTML][HTML] Immunotherapy in sepsis-brake or accelerate?
F Steinhagen, SV Schmidt, JC Schewe… - Pharmacology & …, 2020 - Elsevier
Sepsis, a life threating syndrome characterized by organ failure after infection, is the most
common cause of death in hospitalized patients. The treatment of sepsis is generally …
common cause of death in hospitalized patients. The treatment of sepsis is generally …
[PDF][PDF] Immunotherapy in sepsis-brake or accelerate?
F Steinhagen, SV Schmidt, JC Schewe, K Peukert - 2020 - researchgate.net
Folkert Steinhagen a,⁎, Susanne V. Schmidt b, Jens-Christian Schewe a, Konrad Peukert a,
Dennis M. Klinman c, Christian Bode aa Department of Anesthesiology and Critical Care …
Dennis M. Klinman c, Christian Bode aa Department of Anesthesiology and Critical Care …
Immunotherapy in sepsis-brake or accelerate?
F Steinhagen, SV Schmidt, JC Schewe… - Pharmacology & …, 2020 - europepmc.org
Sepsis, a life threating syndrome characterized by organ failure after infection, is the most
common cause of death in hospitalized patients. The treatment of sepsis is generally …
common cause of death in hospitalized patients. The treatment of sepsis is generally …
Immunotherapy in sepsis-brake or accelerate?
F Steinhagen, SV Schmidt, JC Schewe, K Peukert… - 2020 - cabidigitallibrary.org
Sepsis, a life threating syndrome characterized by organ failure after infection, is the most
common cause of death in hospitalized patients. The treatment of sepsis is generally …
common cause of death in hospitalized patients. The treatment of sepsis is generally …
Immunotherapy in sepsis-brake or accelerate?
F Steinhagen, SV Schmidt… - Pharmacology & …, 2020 - pubmed.ncbi.nlm.nih.gov
Sepsis, a life threating syndrome characterized by organ failure after infection, is the most
common cause of death in hospitalized patients. The treatment of sepsis is generally …
common cause of death in hospitalized patients. The treatment of sepsis is generally …